Showing 1 - 4 of 4
Objective: To estimate the economic value of pharmacological treatment of type 2 diabetes mellitus in overweight and obese patients using orlistat in addition to standard diabetes therapy (i.e., a sulphonlyurea, metformin or insulin) and weight management strategies as compared with standard...
Persistent link: https://www.econbiz.de/10005243210
Introduction: The objective of this study was to assess the cost effectiveness of a continuous combined oral preparation of norethisterone (norethindrone) acetate and ethinylestradiol (NA/EE) [FemHRT(R)] as both a first-line and second-line therapy for menopausal women. Perspective: Third-party...
Persistent link: https://www.econbiz.de/10005590287
Objective: To assess the cost effectiveness of nasal calcitonin (Miacalcin(R)) compared with no therapy, alendronate or etidronate in the treatment of postmenopausal women with previous osteoporotic fracture. Design and setting: Meta-analysis followed by economic analysis. Perspective: A...
Persistent link: https://www.econbiz.de/10005449053
Rheumatoid arthritis (RA) is a chronic, disabling, inflammatory polyarthritis that affects patient well-being and QOL. Many disease-modifying antirheumatic drugs (DMARDs) are available for treating RA but patients are often refractory to treatment. The goal of treatment is to improve both...
Persistent link: https://www.econbiz.de/10005449315